Menovar announced that its wholly-owned subsidiary Ningbo Menohua Tiankang Pharmaceutical Co., Ltd. recently received the “Drug Registration Certificate” for febustel tablets approved and issued by the State Drug Administration. The name of the drug is febustel tablets, and the dosage form is 20 mg, 40 mg. The application is drug registration. The registration classification is 4 types of chemical drugs, the acceptance numbers are CYHS2402255 and CYHS2402254, the drug approval number is Sinopharm standard H20256169, Sinopharm standard H20256168, and the drug approval number is valid until December 2, 2030. The drug is indicated for long-term treatment of hyperuricemia in patients with gout.

Menovar announced that its wholly-owned subsidiary Ningbo Menohua Tiankang Pharmaceutical Co., Ltd. recently received the “Drug Registration Certificate” for febustel tablets approved and issued by the State Drug Administration. The name of the drug is febustel tablets, and the dosage form is 20 mg, 40 mg. The application is drug registration. The registration classification is 4 types of chemical drugs, the acceptance numbers are CYHS2402255 and CYHS2402254, the drug approval number is Sinopharm standard H20256169, Sinopharm standard H20256168, and the drug approval number is valid until December 2, 2030. The drug is indicated for long-term treatment of hyperuricemia in patients with gout.